Search

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) has celebrated its 25th anniversary with some 550 invited guests. At the same time, the Board of Directors honored five individuals to whom the MDC owes a large debt of gratitude, especially during the early years.

Transferring MDC inventions into pharmaceuticals and therapies – this is the mission driving MDC’s department of technology transfer. Their latest achievement, a pharmaceutical substance for atrial fibrillation developed by MDC spin-off OMEICOS Therapeutics, is now entering clinical trials.

The transposon system by MDC researcher Zsuzsanna Izsvák is part a new gene therapy project, funded with 2.8 million euros.

Reliably predicting the onset and trajectory of a disease might seem like a distant dream. But a European consortium is aiming to achieve exactly this using a set of emerging technologies with the analysis of single cells at their core.

To get a different perspective on chirality, it is worth paying a visit to the Max Rubner House, where an art installation by Ulrike Mohr on the subject of chirality has been on display since early July.

Subscription fees for scientific journals are rising faster than inflation. Even well funded...